Serum C-Reactive Protein and Risk of Cardiovascular Events in Middle-Aged and Older Chinese Population

American Journal of Cardiology

Volumn 103, Issue 12, 2009, Pages 1727-1731

  Jiang, Shan ^a   Bao, Yuqian ^a   Hou, Xuhong ^a   Fang, Qichen ^a   Wang, Chen ^a   Pan, Jiemin ^a   Zuo, Yuhua ^b   Zhong, Wenhong ^c   Xiang, Kunsan ^a   Jia, Weiping ^a  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

^b Caoyang Health Center   (China)

^c Huayang Health Center   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDIABETIC AGENT; C REACTIVE PROTEIN; INSULIN; LIPID;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BLOOD PRESSURE; BODY MASS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHINESE; DIABETES MELLITUS; DISEASE COURSE; DYSLIPIDEMIA; FEMALE; HAZARD RATIO; HUMAN; HYPERTENSION; INCIDENCE; ISCHEMIC HEART DISEASE; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; OBESITY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SMOKING; STROKE;

ADULT; AGE DISTRIBUTION; AGE FACTORS; AGED; AGED, 80 AND OVER; C-REACTIVE PROTEIN; CARDIOVASCULAR DISEASES; CHINA; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; NEPHELOMETRY AND TURBIDIMETRY; PROGNOSIS; RETROSPECTIVE STUDIES; RISK FACTORS; SEX DISTRIBUTION; SURVIVAL RATE; YOUNG ADULT;

EID: 67649631811     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2009.02.028     Document Type: Article

References (22)

1. Ridker P.M. High-sensitivity C-reactive protein and cardiovascular risk: rationale for screening and primary prevention. Am J Cardiol 92 (2003) 17K-22K
2. Jialal I., Devaraj S., and Venugopal S.K. C-reactive protein: risk marker or mediator in atherothrombosis?. Hypertension 44 (2004) 6-11
3. Ridker P.M., Buring J.E., Cook N.R., and Rifai N. C-reactive protein, the metabolic syndrome, and risk of incident cardiovascular events: an 8-year follow-up of 14,719 initially healthy American women. Circulation 107 (2003) 391-397
4. Rutter M.K., Meigs J.B., Sullivan L.M., D'Agostino Sr. R.B., and Wilson P.W. C-reactive protein, the metabolic syndrome, and prediction of cardiovascular events in the Framingham offspring study. Circulation 110 (2004) 380-385
5. Ridker P.M., Danielson E., Fonseca F.A., Genest J., Gotto Jr. A.M., Kastelein J.J., Koenig W., Libby P., Lorenzatti A.J., MacFadyen J.G., Nordestgaard B.G., Shepard J., Willerson J.T., Glynn R.J., and JUPITER Study Group. Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. N Engl J Med 359 (2008) 2195-2207
6. Centers for Disease Control/American Heart Association. Workshop on Inflammatory Markers, and Cardiovascular Disease: Application to Clinical and Public Health Care Practice: Atlanta, March 14 to 15 (2002), Centers for Disease Control and Prevention, Atlanta
7. Pearson T.A., Mensah G.A., Alexander R.W., Anderson J.L., Cannon III R.O., Criqui M., Fadl Y.Y., Fortmann S.P., Hong Y., Myers G.L., Rifai N., Smith Jr. S.C., Taubert K., Tracy R.P., Vinicor F., and Centers for Disease Control and Prevention and American Heart Association. Markers of inflammation and cardiovascular disease: application to clinical and public health practice: a statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation 107 (2003) 499-511
8. Albert M.A., Glynn R.J., Buring J., and Ridker P.M. C-reactive protein levels among women of various ethnic groups living in the United States (from the Women's Health Study). Am J Cardiol 93 (2004) 1238-1242
9. Khera A., McGuire D.K., Murphy S.A., Stanek H.G., Das S.R., Vongpatanasin W., Wians Jr. F.H., Grundy S.M., and de Lemos J.A. Race and gender differences in C-reactive protein levels. J Am Coll Cardiol 46 (2005) 464-469
10. Saito I., Sato S., Nakamura M., Kokubo Y., Mannami T., Adachi H., Konishi M., Okada K., Iso H., Kario K., Ohsuzu F., Momiyama Y., and Tsushima M. A low level of C-reactive protein in Japanese adults and its association with cardiovascular risk factors: the Japan NCVC-Collaborative Inflammation Cohort (JNIC) study. Atherosclerosis 194 (2007) 238-244
11. Ye X., Yu Z., Li H., Franco O.H., Liu Y., and Lin X. Distributions of C-reactive protein and its association with metabolic syndrome in middle-aged and older Chinese people. J Am Coll Cardiol 49 (2007) 1798-1805
12. Bao Y.Q., Jia W.P., Chen L., Lu J.X., and Xiang K.S. Association between C-reactive protein level and metabolic syndrome and components thereof. Zhonghua Yi Xue Za Zhi 86 (2006) 2105-2109
13. Cao Y., DiGiacomo M., Du H.Y., Ollerton E., and Davidson P. Cardiovascular disease in Chinese women: an emerging high-risk population and implications for nursing practice. J Cardiovasc Nurs 23 (2008) 386-394
14. Jiang B., Wang W.Z., Chen H., Hong Z., Yang Q.D., Wu S.P., Du X.L., and Bao Q.J. Incidence and trends of stroke and its subtypes in China: results from three large cities. Stroke 37 (2006) 63-68
15. Jia W.P., Xiang K.S., Chen L., Lu J.X., and Wu Y.M. Epidemiological study on obesity and its comorbidities in urban Chinese older than 20 years of age in Shanghai, China. Obes Rev 3 (2002) 157-165
16. Jia W.P., Pang C., Chen L., Bao Y.Q., Lu J.X., Lu H.J., Tang J.L., Wu Y.M., Zuo Y.H., Jiang S.Y., and Xiang K.S. Epidemiological characteristics of diabetes mellitus and impaired glucose regulation in a Chinese adult population: the Shanghai Diabetes Studies, a cross-sectional 3-year follow-up study in Shanghai urban communities. Diabetologia 50 (2007) 286-292
17. Dhingra R., Gona P., Nam B.H., D'Agostino Sr. R.B., Wilson P.W., Benjamin E.J., and O'Donnell C.J. C-reactive protein, inflammatory conditions, and cardiovascular disease risk. Am J Med 120 (2007) 1054-1062
18. Zhou B.F. Effect of body mass index on all-cause mortality and incidence of cardiovascular diseases-report for meta-analysis of prospective studies open optimal cut-off points of body mass index in Chinese adults. Biomed Environ Sci 15 (2002) 83-96
19. Truelsen T., Mähönen M., Tolonen H., Asplund K., Bonita R., Vanuzzo D., and WHO MONICA Project. Trends in stroke and coronary heart disease in the WHO MONICA Project. Stroke 34 (2003) 1346-1352
20. Wu Z., Yao C., Zhao D., Wu G., Wang W., Liu J., Zeng Z., and Wu Y. Sino-MONICA Project: a collaborative study on trends and determinants in cardiovascular diseases in China, part I: morbidity and mortality monitoring. Circulation 103 (2001) 462-468
21. Everett B.M., Kurth T., Buring J.E., and Ridker P.M. The relative strength of C-reactive protein and lipid levels as determinants of ischemic stroke compared with coronary heart disease in women. J Am Coll Cardiol 48 (2006) 2235-2242
22. Arima H., Kubo M., Yonemoto K., Doi Y., Ninomiya T., Tanizaki Y., Hata J., Matsumura K., Iida M., and Kiyohara Y. High-sensitivity C-reactive protein and coronary heart disease in a general population of Japanese: the Hisayama study. Arterioscler Thromb Vasc Biol 28 (2008) 1385-1391